http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009526818-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-7028
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-6615
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-117
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-6615
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-55
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-27
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2007-02-14-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2009-07-23-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2009526818-A
titleOfInvention Certain combinations of phytate and zinc
abstract The present invention relates to a quantitative combination of phytate and zinc in synergistic proportions for use in the treatment of hydroxyapatite crystallization. Advantageously, the combination is a phytate and zinc molar ratio of greater than 4: 1. The invention also relates to the use of the combination for the manufacture of a medicament for use in the treatment, prevention and / or avoidance of crystallization of hydroxyapatite in humans.
priorityDate 2006-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H10182383-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005044278-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419579352
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419491806
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24341
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID892
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID644191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419572902
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID890
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414854036
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID447961905
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134129222
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID414854372
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID115276
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1003
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID644191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID452232359
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID482
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID23994
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415816940
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411550721
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID409431953
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID16683004
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419535600
http://rdf.ncbi.nlm.nih.gov/pubchem/anatomy/ANATOMYID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4737
http://rdf.ncbi.nlm.nih.gov/pubchem/taxonomy/TAXID10116
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419526858
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID33005
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458437694

Total number of triples: 64.